Our results also demonstrated that AMPK-NF-κB signaling in metformin-treated breast cancer cells participated in THP-1 polarization, where blockade of AMPK and NF-κB with specific inhibitors diminished the effect of metformin in breast cancer cells. Here, NFKB1 is linked to breast carcinoma.